-+ 0.00%
-+ 0.00%
-+ 0.00%

Spyre Therapeutics prices upsized 6.5 million-share offering at USD 62 per share

PUBT·04/15/2026 02:41:34
Listen to the news
Spyre Therapeutics prices upsized 6.5 million-share offering at USD 62 per share
  • Spyre Therapeutics priced an upsized underwritten public offering of 6,500,000 common shares at USD 62 per share.
  • Gross proceeds expected at about USD 403 million before underwriting discounts and offering expenses.
  • Underwriters received a 30-day option to buy additional common shares worth up to about USD 60.5 million at offering price less underwriting discount.
  • Closing expected on or about April 16, 2026, subject to customary conditions.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Spyre Therapeutics Inc. published the original content used to generate this news brief on April 14, 2026, and is solely responsible for the information contained therein.